1. Home
  2. AAME vs MDXH Comparison

AAME vs MDXH Comparison

Compare AAME & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$1.75

Market Cap

41.4M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.44

Market Cap

41.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAME
MDXH
Founded
1968
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Life Insurance
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
41.4M
41.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AAME
MDXH
Price
$1.75
$0.44
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
14.8K
758.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$188,227,000.00
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
$7.64
N/A
Revenue Growth
0.77
N/A
52 Week Low
$1.59
$0.45
52 Week High
$3.71
$5.33

Technical Indicators

Market Signals
Indicator
AAME
MDXH
Relative Strength Index (RSI) 37.67 18.95
Support Level $1.59 N/A
Resistance Level $3.16 $3.79
Average True Range (ATR) 0.10 0.05
MACD 0.01 0.04
Stochastic Oscillator 43.33 11.12

Price Performance

Historical Comparison
AAME
MDXH

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: